title: Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity.
abstract: There is strong epidemiological evidence that Chlamydia infection can lead to exacerbation of asthma. However, the mechanism(s) whereby chlamydial infection, which normally elicits a strong Th type 1 (Th1) immune response, can exacerbate asthma, a disease characterized by dominant Th type 2 (Th2) immune responses, remains unclear. In the present study, we show that Chlamydia muridarum infection of murine bone marrow-derived dendritic cells (BMDC) modulates the phenotype, cytokine secretion profile, and Ag-presenting capability of these BMDC. Chlamydia-infected BMDC express lower levels of CD80 and increased CD86 compared with noninfected BMDC. When infected with Chlamydia, BMDC secrete increased TNF-alpha, IL-6, IL-10, IL-12, and IL-13. OVA peptide-pulsed infected BMDC induced significant proliferation of transgenic CD4(+) DO11.10 (D10) T cells, strongly inhibited IFN-gamma secretion by D10 cells, and promoted a Th2 phenotype. Intratracheal transfer of infected, but not control noninfected, OVA peptide-pulsed BMDC to naive BALB/c mice, which had been i.v. infused with naive D10 T cells, resulted in increased levels of IL-10 and IL-13 in bronchoalveolar lavage fluid. Recipients of these infected BMDC showed significant increases in airways resistance and decreased airways compliance compared with mice that had received noninfected BMDC, indicative of the development of airways hyperreactivity. Collectively, these data suggest that Chlamydia infection of DCs allows the pathogen to deviate the induced immune response from a protective Th1 to a nonprotective Th2 response that could permit ongoing chronic infection. In the setting of allergic airways inflammation, this infection may then contribute to exacerbation of the asthmatic phenotype.
authors.affiliation: School of Biomedical Sciences and The Asthma and Respiratory Diseases Priority Research Centre, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.
authors.forename: Gerard E
authors.initials: GE
authors.lastname: Kaiko
authors.forename: Simon
authors.initials: S
authors.lastname: Phipps
authors.forename: Danica K
authors.initials: DK
authors.lastname: Hickey
authors.forename: Chuan En
authors.initials: CE
authors.lastname: Lam
authors.forename: Philip M
authors.initials: PM
authors.lastname: Hansbro
authors.forename: Paul S
authors.initials: PS
authors.lastname: Foster
authors.forename: Kenneth W
authors.initials: KW
authors.lastname: Beagley
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D016535:Bronchial Hyperreactivity / Q000276:immunology* / Q000382:microbiology / Q000503:physiopathology*; D002478:Cells, Cultured; D002690:Chlamydia Infections / Q000276:immunology* / Q000503:physiopathology*; D023502:Chlamydia muridarum / Q000276:immunology*; D018920:Coculture Techniques; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology*; D016130:Immunophenotyping; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D008822:Mice, Transgenic; D018418:Th2 Cells / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology
chemical_list: D016207:Cytokines